Literature DB >> 9566900

Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun.

A Zagariya1, S Mungre, R Lovis, M Birrer, S Ness, B Thimmapaya, R Pope.   

Abstract

Tumor necrosis factor alpha (TNF alpha) is a key regulatory cytokine whose expression is controlled by a complex set of stimuli in a variety of cell types. Previously, we found that the monocyte/macrophage-enriched nuclear transcription factor C/EBPbeta played an important role in the regulation of the TNF alpha gene in myelomonocytic cells. Abundant evidence suggests that other transcription factors participate as well. Here we have analyzed interactions between C/EBPbeta and c-Jun, a component of the ubiquitously expressed AP-1 complex. In phorbol myristate acetate (PMA)-treated Jurkat T cells, which did not possess endogenous C/EBPbeta, expression of c-Jun by itself had relatively little effect on TNF alpha promoter activity. However, the combination of C/EBPbeta and c-Jun was synergistic, resulting in greater than 130-fold activation. This effect required both the leucine zipper and DNA binding domains, but not the transactivation domain, of c-Jun, plus the AP-1 binding site centered 102/103 bp upstream of the transcription start site in the TNF alpha promoter. To determine if C/EBPbeta and c-Jun might cooperate to regulate the cellular TNF alpha gene in myelomonocytic cells, U937 cells that possess endogenous C/EBPbeta and were stably transfected with either wild-type c-Jun or the transactivation domain deletion mutant (TAM-67) were examined. U937 cells expressing ectopic wild-type c-Jun or TAM-67 secreted over threefold more TNF alpha than the control line in response to PMA plus lipopolysaccharide. Transient transfection of the U937 cells expressing TAM-67 suggested that TAM-67 binding to the -106/-99-bp AP-1 binding site cooperated with endogenous C/EBPbeta in the activation of the -120 TNF alpha promoter-reporter. DNA binding assays using oligonucleotides derived from the TNF alpha promoter suggested that C/EBPbeta and c-Jun interact in vitro and that the interaction may be DNA dependent. Our data demonstrate that the TNF alpha gene is regulated by the interaction of the ubiquitous AP-1 complex protein c-Jun and the monocyte/macrophage-enriched transcription factor C/EBPbeta and that this interaction contributes to the expression of the cellular TNF alpha gene in myelomonocytic cells. This interaction was unique in that it did not require the c-Jun transactivation domain, providing new insight into the cell-type-specific regulation of the TNF alpha gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566900      PMCID: PMC110660          DOI: 10.1128/MCB.18.5.2815

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.

Authors:  Y Miyazaki; K Araki; C Vesin; I Garcia; Y Kapanci; J A Whitsett; P F Piguet; P Vassalli
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

2.  Regulation of the human TNF promoter by the transcription factor Ets.

Authors:  B Krämer; K Wiegmann; M Krönke
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

3.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

Authors:  M J Elliott; R N Maini; M Feldmann; J R Kalden; C Antoni; J S Smolen; B Leeb; F C Breedveld; J D Macfarlane; H Bijl
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

4.  NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin-1.

Authors:  L Klampfer; T H Lee; W Hsu; J Vilcek; S Chen-Kiang
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

5.  C/EBP beta regulation of the tumor necrosis factor alpha gene.

Authors:  R M Pope; A Leutz; S A Ness
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

6.  The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines.

Authors:  K L Rhoades; S H Golub; J S Economou
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

7.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

Authors:  P A Kern; M Saghizadeh; J M Ong; R J Bosch; R Deem; R B Simsolo
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

8.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

Authors:  G S Hotamisligil; P Arner; J F Caro; R L Atkinson; B M Spiegelman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression.

Authors:  E Kowenz-Leutz; G Twamley; S Ansieau; A Leutz
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

10.  Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.

Authors:  X D Yang; R Tisch; S M Singer; Z A Cao; R S Liblau; R D Schreiber; H O McDevitt
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  27 in total

Review 1.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

Review 2.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

3.  Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.

Authors:  Manisha Juneja; Katharina Ilm; Peter M Schlag; Ulrike Stein
Journal:  Mol Oncol       Date:  2013-06-06       Impact factor: 6.603

4.  Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells.

Authors:  Michael C Lawrence; Bashoo Naziruddin; Marlon F Levy; Andrew Jackson; Kathleen McGlynn
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

5.  Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway Activation.

Authors:  Andrew T Templin; Tanya Samarasekera; Daniel T Meier; Meghan F Hogan; Mahnaz Mellati; Michael T Crow; Richard N Kitsis; Sakeneh Zraika; Rebecca L Hull; Steven E Kahn
Journal:  Diabetes       Date:  2017-07-20       Impact factor: 9.461

6.  Cytokine expression in meconium-induced lungs.

Authors:  Alexander Zagariya; Rama Bhat; Shankararao Navale; Dharmapuri Vidyasagar
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

Review 7.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

8.  An NF-kappaB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells.

Authors:  Tiphanie Gomard; Henri-Alexandre Michaud; Denis Tempé; Kevin Thiolon; Mireia Pelegrin; Marc Piechaczyk
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

9.  Activator protein-1 activation in acute lung injury.

Authors:  Ren-Feng Guo; Alex B Lentsch; J Vidya Sarma; Lei Sun; Niels C Riedemann; Shannon D McClintock; Stephanie R McGuire; Nico Van Rooijen; Peter A Ward
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells.

Authors:  Yi Huang; Erin R Hager; Dawn L Phillips; Valerie R Dunn; Amy Hacker; Benjamin Frydman; John A Kink; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton; Robert A Casero; Nancy E Davidson
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.